95 related articles for article (PubMed ID: 15137676)
21. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
22. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
[TBL] [Abstract][Full Text] [Related]
23. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
Min KW; Seo IS; Pitha J
Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
[TBL] [Abstract][Full Text] [Related]
26. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
Parwani AV; Herawi M; Epstein JI
Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156
[TBL] [Abstract][Full Text] [Related]
27. [Melanotic adenocarcinoma of the uterus. Neuroendocrine tumor of the uterus].
Bertrand G
Ann Pathol; 1988; 8(4-5):295-304. PubMed ID: 3214497
[TBL] [Abstract][Full Text] [Related]
28. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
29. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
31. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
Cho MS; Lee SN; Sung SH; Han WS
Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
33. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
35. Primary pulmonary choriocarcinoma combined with adenocarcinoma.
Yamamoto S; Tanaka H; Takeo H; Yasuda K; Mastukuma S
Pathol Int; 2006 Jul; 56(7):402-7. PubMed ID: 16792550
[TBL] [Abstract][Full Text] [Related]
36. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
37. Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report.
Cabibi D; Martorana A; Cappello F; Barresi E; Di Gangi C; Rodolico V
BMC Cancer; 2006 Mar; 6():47. PubMed ID: 16509974
[TBL] [Abstract][Full Text] [Related]
38. Histogenesis of metaplastic breast carcinoma and axillary nodal metastases.
Osako T; Horii R; Ogiya A; Iijima K; Iwase T; Akiyama F
Pathol Int; 2009 Feb; 59(2):116-20. PubMed ID: 19154267
[TBL] [Abstract][Full Text] [Related]
39. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.
Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F
J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204
[TBL] [Abstract][Full Text] [Related]
40. Isolated solitary ducts (naked ducts) in adipose tissue: a specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate.
Bandyopadhyay S; Basturk O; Coban I; Thirabanjasak D; Liang H; Altinel D; Adsay NV
Am J Surg Pathol; 2009 Mar; 33(3):425-9. PubMed ID: 19092633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
